CClinicalTrials.gg
CompletedNCT03265756Updated Nov 21, 2018

Multimometer - Vital Signs Device for Diagnosis of Pneumonia

An observational study in Pneumonia, sponsored by University of Alberta. Completed at 2 sites in 2 countries. Open to participants aged Up to 5 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-21.

Sponsored by University of Alberta · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
350
Ages
Up to 5 Years
Sex
All
01

Study summary

Pneumonia is a major cause of illness in young children. The investigators are developing and testing a new thermometer like device called Multimometer, to measure the respiration rate (RR), temperature, heart rate (HR) and the degree of blood oxygenation (SpO2) of children who may suffer from pneumonia. These are called vital signs and their measurements greatly help to diagnose pneumonia.

In the first part of the study, and in order to optimize and better align the size of the device with the face, the investigators will measure the average size and dimensions of young children's face. In the second part of the study, the investigators will compare the vital signs measurements with measurements obtained by other commonly used devices in ill children who are suspected to suffer from pneumonia.

Read the detailed description

A. Improve the universality of the mouth-interface using facial anthropometry techniques.

For this first part of the study, the investigators will use a portable 3D camera (as previously used by our group) to acquire 250 3D facial images of healthy children under 5yrs of age in the DRC. While in hospital/clinic, the investigators will use a three-dimension (3D) special camera to obtain an image of the child's face. The child can sit on the lap of the parent and we will take the image. The image acquisition takes less than 30 seconds. There are no specific requirements from the child, and the image can be taken if the child is asleep or awake, cry or settled. No medical or identifying information will be collected.

All the computerized images will be cluster analyzed (using previously established methodologies from the Technion, Israel) and three 3D average faces of all small, medium and large faces will be constructed. The investigators will use these "faces" to design better Multimometers with improved mouth-interface for this population.

B. Integrate into the current device a reflexive pulse oximeter sensor which will allow measurements of oxygen saturation and heart rate.

For the addition of HR and SpO2 measurements, the investigators will integrate a reflective pulse oximetry chip into the probe. Together with the manufacturer (RespiDx Inc., Israel) the investigators will design and manufacture optimal prototype devices suitable for performing clinical trials on this population.

C. Compare vital signs measurements by Multimometer® to simultaneous vital signs measurement using conventional devices.

For this part of the study, repeated (x5 times) measurements of the 4 vital signs in 50 young children (under 5 yrs) in hospital/clinics in Butembo DRC with suspected pneumonia, will be recorded using the Multimometer. These signs will also be measured at the same time, by conventional methods (regular thermometers for temperature, observed respiratory rate using recorded chest movements and end-tidal carbon dioxide (CO2) for respiratory rate, standard pulse oximeters for oxygen saturation and heart rate). All these measurements take less than 5 minutes. The investigators will repeat these sets approximately 5 times during the same day in the hospital or during a clinic visit. The vital signs will be compared between the two methods using Pearson's correlation coefficient and using Bland-Altman plots for agreement.

02

Conditions studied

  • Pneumonia

Browse trials for

03

Who can participate

Ages eligible
Up to 5 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children under 5y of age

Inclusion criteria

For the first part of the study (3D facial images):

  • Healthy children under 5y of age

For the second phase of the study (Comparison of vital signs):

  • Children under 5y of age with suspected pneumonia

Exclusion criteria

Exclusion Criteria:

  • Children older than 5y of age
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
350 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy children

    250 3D facial images of healthy children under 5yrs of age in the Democratic Republic of Congo (DRC).

  • Suspected Pneumonia

    50 young children (under 5 yrs) in hospital/clinics in Butembo DRC with suspected pneumonia

    Device: Multimometer

Interventions

  • DeviceMultimometer

    A device for measuring respiration rate, temperature, heart rate and the degree of blood oxygenation of children

05

What researchers measure

Primary outcomes

  1. Vital Signs Comparison

    Measurements of respiration rate, temperature, heart rate and the degree of blood oxygenation of children

    Time frame: 2018

Secondary outcomes

  1. 3D facial images

    Measurements of facial dimensions and contour

    Time frame: 2017-2018

06

Study locations

2 sites
  • University of Alberta
    Edmonton, Alberta T6G2C6, Canada
  • AHFIA (Association for Health Innovation in Africa)
    Butembo, North Kivu, Congo, The Democratic Republic of the
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03265756
Lead sponsor
University of Alberta
Collaborators
Grand Challenges Canada
Responsible party
Israel Amirav (MD, University of Alberta) — Principal investigator
First posted
Aug 29, 2017
Start date
Jun 20, 2017
Primary completion
Sep 30, 2018
Completion
Sep 30, 2018
Last update
Nov 21, 2018

Study contacts

Israel Amirav
principal investigator · University of Alberta

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion